Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%

Healthcare

Page 42
  1. Mar 26, 2026 · 04:16 · NGMD

    Nugen files patent for needle-free injection nozzle

    Nugen files patent for needle-free injection nozzle

    01
  2. Mar 25, 2026 · 18:47 · DHT

    DRI Healthcare closes $250M (U.S.) offering of notes

    DRI Healthcare closes $250M (U.S.) offering of notes

    02
  3. Mar 25, 2026 · 17:15 · NGMD

    NuGen Files Needle-Free Nozzle Patent as Stock Tests Multi-Year Lows

    NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology

    03
  4. Mar 25, 2026 · 17:05 · CSCI

    COSCIENS Sheds German Subsidiaries and $11M Pension Liability as Cash Burn Outpaces Declining Revenue

    COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

    04
  5. Mar 25, 2026 · 16:22 · GSD

    Devonian Health Faces Liquidity Cliff as Distribution Revenue Dries Up and Biotech Pivot Demands Fresh Capital

    Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026

    05
  6. Mar 25, 2026 · 16:00 · MRVL

    Marvel Biosciences selects Novotech for MB-204 trial

    Marvel Biosciences selects Novotech for MB-204 trial

    06
  7. Mar 25, 2026 · 13:37 · DHT

    DRI Healthcare Closes $250M Debt Roll as Leverage Climbs and EBITDA Guidance Slips

    DRI Healthcare Trust Announces Closing of US$250 Million of Senior Secured Notes

    07
  8. Mar 25, 2026 · 12:27 · AIAI

    NetraMark’s AI Platform Gains Oncology Validation as Cash Burn Outpaces Revenue Growth

    Netramark, FMP to analyze ROME oncology data

    08
  9. Mar 25, 2026 · 08:20 · LOBE

    Lobe Sciences Trims Liabilities and Warrants as Cash Pile Grows, But Clinical Catalysts Remain Unpriced

    Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update

    09
  10. Mar 25, 2026 · 07:31 · CHER

    Cheelcare Scales Revenue but Cash Burn Threatens Runway as Stock Fades from Peak

    Cheelcare Announces Third Quarter 2026 Financial Results

    10
  11. Mar 25, 2026 · 07:30 · MRVL

    Marvel Biosciences Secures Modest Grant to Bridge Phase I, But $4.3M Debt Overhang Looms Over Clinical Ambitions

    Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

    11
  12. Mar 25, 2026 · 04:59 · AFV

    TelyRx QT Filing Clears Final Hurdles as Financing Target Slashes to $20M

    Apolo V files filing statement for QT

    12
  13. Mar 24, 2026 · 20:42 · XRTX

    XORTX Therapeutics shareholders approve 1:10 rollback

    XORTX Therapeutics shareholders approve 1:10 rollback

    13
  14. Mar 24, 2026 · 17:42 · AIDR

    Rocket Doctor AI expands California coverage

    Rocket Doctor AI expands California coverage

    14
← Newer Older →